Blog

Which drug may work by via the following mechanism? “Smooth muscle relaxation from phosphodiesterase inhibition and possibly adenosine antagonism”

Select the row which is the most accurate   Clinical scenario Examples of likely organisms Primary treatments Secondary treatments 1 Early syphilis Treponema pallidum Oral doxycycline Ceftriaxone IM daily for 10 days 2 Uncomplicated gonorrhea Neisseria gonorrhea, 50% co-infected with chlamydia Ceftriaxone IM plus oral azithromycin   3 Uncomplicated urinary tract infection E. coli, staph saprophyticus Tetracycline   4 Community-acquired pneumonia, no points or comorbidities, young patient with good resources Mycoplasma, Chlamydia pneumonia, viral, pneumococcus Ceftriaxone IV + azithromycin  

You see a young patient in the clinic who is febrile, has a white count elevation, and has a chest X-ray read as “left lower lobe pneumonia” by the radiologist. She has no co-morbidities. She is employed, has a home, and except for a fever of 101 degrees F, cough, slight pain on inspiration, tachycardia (HR = 110), auscultatory findings over the LLL, and slight shortness of breath, is healthy without co-morbidities. Which answer correctly addresses the issues of: site of treatment / overall risk / drug choice?  

Which side effect/drug choice is most likely to be seen in a clinic patient?  

Regarding the metabolism acetaminophen, this drug first undergoes first undergoes what type metabolism in the liver:

You are seeing a 56-year-old Black male without any history of cardiovascular disease or diabetes. His LDL cholesterol level is 108 mg/dL, and his 10-year ASCVD risk is calculated to be 5.5%. He is currently on no medications.  His Coronary Artery Calcium score at this time is zero.   Select the appropriate intensity of statin therapy indicated for this patient.  

A 70-year-old man with chronic kidney disease (eGFR 45 mL/min/1.73 m²) and stage 1 hypertension (138/88 mm Hg) is evaluated. He has no diabetes or history of heart failure. What is the most appropriate initial pharmacotherapy?

A 60-year-old man with type 2 diabetes has an average office blood pressure of 147/88 mm Hg similar to home readings. His estimated 10-year ASCVD risk is 12%. What is the most appropriate initial management based on 2025 ACC/AHA Hypertension guidelines?

A 66-year-old man with a history of myocardial infarction 6 months ago, hypertension, and symptomatic peripheral arterial disease presents for follow-up. His current medications include aspirin, metoprolol, and rosuvastatin 40 mg daily. Laboratory studies show LDL-C of 60 mg/dL. He reports no adverse effects from his medications. Which of the following is the most appropriate next step in managing his lipid profile?

A 52-year-old African American man presents for a routine check-up. His blood pressure is measured twice in the office as 132/84 mm Hg and 134/82 mm Hg. He has no history of cardiovascular disease, diabetes, or chronic kidney disease. Home blood pressure monitoring averages 131/82 mm Hg over the past week. What is the most appropriate classification of his blood pressure according to the 2025 hypertension guidelines?